1-4 of 4
Ignazio Barbagallo
Close
Sort by
Journal Articles

Bortezomib Could Reduce Cell Viability by Activation of Heme Oxygenase 1 in Multiple Myeloma Cells

Daniele Tibullo, Cesarina Giallongo, Ignazio Barbagallo, Piera La Cava, Nunziatina Parrinello, Giovanni Li Volti, Sr., Giuseppe A Palumbo, Concetta Conticello, MD, Francesco Di Raimondo
Journal: Blood
Blood (2012) 120 (21): 5005.
https://doi.org/10.1182/blood.V120.21.5005.5005
Published: 2012
Journal Articles

Heme Oxygenase 1-Induced Resistance to Imatinib In Chronic Myelogenous Leukemia Cells

Daniele Tibullo, Ignazio Barbagallo, Antonio Branca, Cesarina Giallongo, Piera La Cava, Giovanni Li Volti, Giuseppe A Palumbo, MD, Roberto Motterlini, Sr., Angelo Vanella, Sr., Francesco Di Raimondo, MD
Journal: Blood
Blood (2011) 118 (21): 4410.
https://doi.org/10.1182/blood.V118.21.4410.4410
Published: 2011
Journal Articles

Mechanisms of Heme Oxygenase 1-Induced Resistance to Imatinib In CML Cells.

Daniele Tibullo, Ignazio Barbagallo, Antonio Branca, Cesarina Giallongo, Piera La Cava, PhD, Nunziatina Parrinello, Giovanni Li Volti, Angelo Vanella, Fabio Stagno, MD, Giuseppe A Palumbo, MD, Francesco Di Raimondo
Journal: Blood
Blood (2010) 116 (21): 3385.
https://doi.org/10.1182/blood.V116.21.3385.3385
Published: 2010
Journal Articles

Effects of the Second Generation Tyrosin Kinase Inhibitors on Osteogenic Differentiation.

Daniele Tibullo, Ignazio Barbagallo, Cesarina Giallongo, Piera La Cava, PhD, Antonio Branca, Concetta Conticello, MD, Fabio Stagno, MD, Annalisa Chiarenza, MD, Giuseppe A Palumbo, MD, Francesco Di Raimondo
Journal: Blood
Blood (2010) 116 (21): 3386.
https://doi.org/10.1182/blood.V116.21.3386.3386
Published: 2010